Neogen Corporation (NEOG) Analysts See $0.30 EPS

June 17, 2018 - By Vivian Currie

Neogen Corporation (NASDAQ:NEOG) LogoInvestors sentiment increased to 6.71 in 2018 Q1. Its up 5.22, from 1.49 in 2017Q4. It is positive, as 13 investors sold Neogen Corporation shares while 15 reduced holdings. 27 funds opened positions while 161 raised stakes. 90.94 million shares or 167.86% more from 33.95 million shares in 2017Q4 were reported.
State Bank Of Mellon has 661,184 shares. California-based Aperio Ltd Llc has invested 0.01% in Neogen Corporation (NASDAQ:NEOG). North Point Port Managers Oh reported 243,536 shares or 2.8% of all its holdings. North Carolina-based Captrust Finance has invested 0% in Neogen Corporation (NASDAQ:NEOG). Greenleaf Trust stated it has 0% of its portfolio in Neogen Corporation (NASDAQ:NEOG). Gemmer Asset Mngmt Limited Com invested in 72 shares. Wellington Grp Inc Llp accumulated 86,100 shares. Rmb Cap Lc reported 54,391 shares. Conestoga Capital Advsrs Ltd Limited Liability Company stated it has 1.38 million shares. First Republic Invest Mgmt reported 0% of its portfolio in Neogen Corporation (NASDAQ:NEOG). Cambridge Research Advisors accumulated 28,354 shares or 0.02% of the stock. Marco Inv Mngmt Llc holds 3,000 shares. Geode Capital Mgmt Limited Company has invested 0.01% in Neogen Corporation (NASDAQ:NEOG). Tokio Marine Asset Management Ltd accumulated 11,466 shares. Wade G W And Inc has 0.05% invested in Neogen Corporation (NASDAQ:NEOG) for 7,028 shares.

Since January 26, 2018, it had 0 insider buys, and 16 selling transactions for $10.42 million activity. The insider BRADLEY EDWARD sold $417,223. $374,818 worth of stock was sold by REED THOMAS H on Friday, March 23. The insider BOEHM WILLIAM T sold $34,920. 36,000 shares were sold by HERBERT JAMES L, worth $2.57M on Tuesday, May 8. 6,000 shares were sold by PAPESH G BRUCE, worth $358,320. The insider MORRICAL TERRI A sold $1.00 million.

Analysts expect Neogen Corporation (NASDAQ:NEOG) to report $0.30 EPS on July, 17.They anticipate $0.06 EPS change or 25.00 % from last quarter’s $0.24 EPS. NEOG’s profit would be $15.48 million giving it 68.23 P/E if the $0.30 EPS is correct. After having $0.32 EPS previously, Neogen Corporation’s analysts see -6.25 % EPS growth. The stock increased 1.58% or $1.27 during the last trading session, reaching $81.88. About 220,226 shares traded or 7.30% up from the average. Neogen Corporation (NASDAQ:NEOG) has risen 56.69% since June 17, 2017 and is uptrending. It has outperformed by 44.12% the S&P500.

Neogen Corporation (NASDAQ:NEOG) Ratings Coverage

Among 2 analysts covering Neogen Corp (NASDAQ:NEOG), 0 have Buy rating, 0 Sell and 2 Hold. Therefore 0 are positive. Neogen Corp had 2 analyst reports since January 4, 2018 according to SRatingsIntel. Roth Capital maintained Neogen Corporation (NASDAQ:NEOG) on Thursday, January 4 with “Hold” rating. The firm earned “Hold” rating on Monday, March 26 by Stephens.

Neogen Corporation, together with its subsidiaries, develops, makes, and markets various products for food and animal safety worldwide. The company has market cap of $4.22 billion. It operates through two divisions, Food Safety and Animal Safety. It has a 72.72 P/E ratio. The Food Safety segment primarily offers diagnostic test kits and complementary to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells.

More recent Neogen Corporation (NASDAQ:NEOG) news were published by: Benzinga.com which released: “Benzinga’s Daily Biotech Pulse: Hematology Conference In The Spotlight, Dr. Reddy To Launch Generic Opioid …” on June 15, 2018. Also Nasdaq.com published the news titled: “Market Trends Toward New Normal in Neogen, Intuitive Surgical, IDT, Government Properties Income Trust, Everbridge …” on June 13, 2018. Benzinga.com‘s news article titled: “Benzinga’s Daily Biotech Pulse: Clinical Hold For Crispr, Gilead Study Meets Endpoint, Akers Gets Grace Time” with publication date: June 01, 2018 was also an interesting one.

Neogen Corporation (NASDAQ:NEOG) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.